Incorrect Data in Figure and Text: In the Original Contribution entitled “Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth,” published in the November 5, 2008, issue of JAMA (2008;300:2003-2011), an inaccurate statement appeared in the text and incorrect numbers in the text and in a figure. On page 2006 in the third column, the next-to-last full sentence on the page should have read, “The number of detox patients and 12-week buprenorphine-naloxone patients providing urine at weeks 4, 8, and 12 is in Figure 2; 41 detox and 49 12-week buprenorphine-naloxone patients provided samples through week 12.” The numbers of patients with opioid-positive urine test results at weeks 4, 8, and 12 were 28, 22, and 21 in the detox group and 15, 12, and 21 in the buprenorphine-naloxone group. This is incorrectly reported in 2 places: the Results section of the abstract on page 2003 and the paragraph beginning at the end of page 2006. In Figure 2 on page 2007, the total number of patients in the Detox group should have been 46, 41, and 41, respectively. These errors had no effect on any of the results reported.